 Females with external genital warts who meet the eligibility criteria will be randomly allocated in a blinded manner in 1:1 ratio to one of the 2 following study arms: 1 AS101 15 gel or 2 Vehicle. The patients will apply the study drug at home once daily overnight until complete clearance of external genital warts or for up to 14 weeks 98 days. 